UNIVEST FINANCIAL Corp Has $2.38 Million Holdings in CME Group Inc. (NASDAQ:CME)

Key Points

• UNIVEST FINANCIAL Corp reduced its stake in CME Group Inc. by 13.0%, now holding 8,974 shares worth approximately $2.38 million as reported in the latest SEC filing.
• Insiders at CME Group have actively sold shares, with notable transactions including Director Daniel G. Kaye selling 500 shares and Derek Sammann selling 4,650 shares, resulting in significant decreases in their personal ownership percentages.
• Market analysts have provided mixed ratings for CME Group, with price targets ranging from $211.00 to $304.00, reflecting variability in investor sentiment and projected stock performance.

UNIVEST FINANCIAL Corp lessened its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 13.0% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 8,974 shares of the financial services provider's stock after selling 1,339 shares during the quarter. UNIVEST FINANCIAL Corp's holdings in CME Group were worth $2,381,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Wayfinding Financial LLC acquired a new position in shares of CME Group during the first quarter worth $25,000. Cornerstone Planning Group LLC boosted its stake in CME Group by 122.2% during the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider's stock valued at $26,000 after acquiring an additional 55 shares during the last quarter. New Age Alpha Advisors LLC lifted its position in shares of CME Group by 50.0% during the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after purchasing an additional 43 shares during the last quarter. Golden State Wealth Management LLC raised its position in shares of CME Group by 612.5% during the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider's stock valued at $30,000 after acquiring an additional 98 shares in the last quarter. Finally, Alpine Bank Wealth Management bought a new stake in shares of CME Group during the 1st quarter valued at about $32,000. Hedge funds and other institutional investors own 87.75% of the company's stock.

Analyst Ratings Changes

Several research analysts have commented on CME shares. Barclays set a $298.00 target price on shares of CME Group and gave the stock an "equal weight" rating in a research report on Thursday, July 24th. Oppenheimer increased their price target on shares of CME Group from $300.00 to $303.00 and gave the stock an "outperform" rating in a research report on Thursday, July 24th. Piper Sandler increased their price objective on CME Group from $283.00 to $296.00 and gave the stock an "overweight" rating in a report on Tuesday, July 15th. JPMorgan Chase & Co. reduced their price target on CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a report on Thursday, April 24th. Finally, Keefe, Bruyette & Woods raised their target price on CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a report on Thursday, April 24th. Four equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and four have assigned a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $261.93.

CME Group Stock Down 0.6%

Shares of NASDAQ CME traded down $1.83 during mid-day trading on Tuesday, reaching $285.27. 859,852 shares of the company's stock were exchanged, compared to its average volume of 2,362,424. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12. The business has a fifty day simple moving average of $276.13 and a 200 day simple moving average of $264.74. CME Group Inc. has a twelve month low of $196.93 and a twelve month high of $290.79. The firm has a market capitalization of $102.81 billion, a price-to-earnings ratio of 27.62, a PEG ratio of 4.99 and a beta of 0.44.

CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, topping analysts' consensus estimates of $2.91 by $0.05. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same period last year, the business posted $2.56 earnings per share. The firm's quarterly revenue was up 10.4% on a year-over-year basis. As a group, equities analysts expect that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, June 25th. Investors of record on Monday, June 9th were paid a $1.25 dividend. The ex-dividend date of this dividend was Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. CME Group's dividend payout ratio (DPR) is currently 48.40%.

Insiders Place Their Bets

In related news, Director Phyllis M. Lockett sold 1,060 shares of CME Group stock in a transaction dated Monday, May 19th. The shares were sold at an average price of $277.88, for a total transaction of $294,552.80. Following the completion of the sale, the director owned 3,108 shares of the company's stock, valued at approximately $863,651.04. The trade was a 25.43% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Charles P. Carey sold 3,000 shares of the company's stock in a transaction that occurred on Thursday, May 15th. The shares were sold at an average price of $272.56, for a total value of $817,680.00. Following the completion of the transaction, the director directly owned 5,400 shares in the company, valued at $1,471,824. The trade was a 35.71% decrease in their position. The disclosure for this sale can be found here. Insiders sold 5,750 shares of company stock valued at $1,576,294 in the last ninety days. 0.30% of the stock is currently owned by insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.